| abstract |
The present invention provides antagonistic antibodies that bind to the glucagon receptor and methods of use thereof. Anti-glucagon receptor antibodies can be used therapeutically to lower blood glucose levels, and also include diabetes, hyperglycemia, hyperinsulinemia, fasting blood glucose abnormalities, impaired glucose tolerance, abnormal dyslipidemia Or can be present during the prevention and / or treatment of glucose related disorders, including metabolic syndrome. [Figure 1] |